CN103755838B - 一种肝素钠的制备方法 - Google Patents
一种肝素钠的制备方法 Download PDFInfo
- Publication number
- CN103755838B CN103755838B CN201310745559.2A CN201310745559A CN103755838B CN 103755838 B CN103755838 B CN 103755838B CN 201310745559 A CN201310745559 A CN 201310745559A CN 103755838 B CN103755838 B CN 103755838B
- Authority
- CN
- China
- Prior art keywords
- solution
- aqueous
- preparation
- add
- concentration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 229920000669 heparin Polymers 0.000 title claims abstract description 78
- ZFGMDIBRIDKWMY-PASTXAENSA-N heparin Chemical compound CC(O)=N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COS(O)(=O)=O)O[C@@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O[C@H]2[C@@H]([C@@H](OS(O)(=O)=O)[C@@H](O[C@@H]3[C@@H](OC(O)[C@H](OS(O)(=O)=O)[C@H]3O)C(O)=O)O[C@@H]2O)CS(O)(=O)=O)[C@H](O)[C@H]1O ZFGMDIBRIDKWMY-PASTXAENSA-N 0.000 title claims abstract description 56
- 229960001008 heparin sodium Drugs 0.000 title claims abstract description 56
- 238000002360 preparation method Methods 0.000 title claims abstract description 41
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 36
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims abstract description 17
- 108010059892 Cellulase Proteins 0.000 claims abstract description 12
- 229940106157 cellulase Drugs 0.000 claims abstract description 12
- 108010019160 Pancreatin Proteins 0.000 claims abstract description 11
- 229940055695 pancreatin Drugs 0.000 claims abstract description 11
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000012535 impurity Substances 0.000 claims abstract description 9
- 238000004108 freeze drying Methods 0.000 claims abstract description 4
- 239000000243 solution Substances 0.000 claims description 46
- 239000006228 supernatant Substances 0.000 claims description 37
- 239000002244 precipitate Substances 0.000 claims description 32
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 27
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 26
- 238000003756 stirring Methods 0.000 claims description 26
- 238000010792 warming Methods 0.000 claims description 26
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 18
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 18
- 239000007864 aqueous solution Substances 0.000 claims description 17
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 15
- 239000001110 calcium chloride Substances 0.000 claims description 15
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 15
- DPDMMXDBJGCCQC-UHFFFAOYSA-N [Na].[Cl] Chemical compound [Na].[Cl] DPDMMXDBJGCCQC-UHFFFAOYSA-N 0.000 claims description 14
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 13
- 238000006243 chemical reaction Methods 0.000 claims description 12
- 239000008213 purified water Substances 0.000 claims description 10
- 239000000706 filtrate Substances 0.000 claims description 9
- 238000013019 agitation Methods 0.000 claims description 6
- 238000002835 absorbance Methods 0.000 claims description 5
- 230000001105 regulatory effect Effects 0.000 claims 4
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 abstract description 24
- 229960002897 heparin Drugs 0.000 abstract description 22
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 abstract description 12
- 238000004519 manufacturing process Methods 0.000 abstract description 7
- 230000003647 oxidation Effects 0.000 abstract description 6
- 238000007254 oxidation reaction Methods 0.000 abstract description 6
- 230000002378 acidificating effect Effects 0.000 abstract description 2
- 238000010298 pulverizing process Methods 0.000 abstract description 2
- 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 16
- 239000007788 liquid Substances 0.000 description 12
- 238000000034 method Methods 0.000 description 11
- 238000005304 joining Methods 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 239000003814 drug Substances 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 150000003538 tetroses Chemical class 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 238000005352 clarification Methods 0.000 description 3
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 229920002683 Glycosaminoglycan Polymers 0.000 description 2
- 229920002971 Heparan sulfate Polymers 0.000 description 2
- 102000016611 Proteoglycans Human genes 0.000 description 2
- 108010067787 Proteoglycans Proteins 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- SRBFZHDQGSBBOR-LECHCGJUSA-N alpha-D-xylose Chemical compound O[C@@H]1CO[C@H](O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-LECHCGJUSA-N 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 239000002634 heparin fragment Substances 0.000 description 2
- 239000003055 low molecular weight heparin Substances 0.000 description 2
- 229940127215 low-molecular weight heparin Drugs 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 229960003487 xylose Drugs 0.000 description 2
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- 101710132601 Capsid protein Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- MBLBDJOUHNCFQT-UHFFFAOYSA-N N-acetyl-D-galactosamine Natural products CC(=O)NC(C=O)C(O)C(O)C(O)CO MBLBDJOUHNCFQT-UHFFFAOYSA-N 0.000 description 1
- 229930182473 O-glycoside Natural products 0.000 description 1
- 150000008444 O-glycosides Chemical class 0.000 description 1
- 108010059712 Pronase Proteins 0.000 description 1
- 102000011759 adducin Human genes 0.000 description 1
- 108010076723 adducin Proteins 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- 230000001851 biosynthetic effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 125000000600 disaccharide group Chemical group 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007071 enzymatic hydrolysis Effects 0.000 description 1
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 1
- -1 heparin tetrose Chemical class 0.000 description 1
- 210000003630 histaminocyte Anatomy 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 230000005311 nuclear magnetism Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 239000012286 potassium permanganate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- XXPDBLUZJRXNNZ-UHFFFAOYSA-N promethazine hydrochloride Chemical compound Cl.C1=CC=C2N(CC(C)N(C)C)C3=CC=CC=C3SC2=C1 XXPDBLUZJRXNNZ-UHFFFAOYSA-N 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
Claims (22)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310745559.2A CN103755838B (zh) | 2013-12-30 | 2013-12-30 | 一种肝素钠的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310745559.2A CN103755838B (zh) | 2013-12-30 | 2013-12-30 | 一种肝素钠的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103755838A CN103755838A (zh) | 2014-04-30 |
CN103755838B true CN103755838B (zh) | 2016-01-20 |
Family
ID=50523181
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310745559.2A Active CN103755838B (zh) | 2013-12-30 | 2013-12-30 | 一种肝素钠的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103755838B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105884936A (zh) * | 2014-10-17 | 2016-08-24 | 北京海吉星医疗科技有限公司 | 一种肝素钠的制备方法 |
CN115028757A (zh) * | 2022-06-29 | 2022-09-09 | 江苏麦德森制药有限公司 | 一种肝素钠的脱色方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100560730C (zh) * | 2007-03-16 | 2009-11-18 | 由守谊 | 一种类肝素的制备方法 |
EP2349338A2 (fr) * | 2008-09-26 | 2011-08-03 | Adocia | Complexe constitue d'un polysaccharide et d'une hpb |
-
2013
- 2013-12-30 CN CN201310745559.2A patent/CN103755838B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN103755838A (zh) | 2014-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2930637T3 (es) | Copolímeros de injerto de dextrano-poli-alfa-1,3-glucano y métodos de síntesis de los mismos | |
EP2209816B1 (en) | Process for the preparation of purified beta-(1,3)-d-glucans | |
CN114901701A (zh) | 一种超低分子量透明质酸及其制备方法 | |
US8614070B2 (en) | Process for the co-production of chitin, its derivatives and polymers containing glucose, mannose and/or galactose, by the fermentation of the yeast Pichia pastoris | |
CN101260160A (zh) | 一种部分氧化海藻酸钠的方法 | |
WO2008062998A1 (en) | Method for purifying hyaluronic acid | |
CN106103726A (zh) | 从农业废弃物分级分离寡糖的方法 | |
WO2018121581A1 (zh) | 多糖的臭氧降解方法 | |
WO2021081999A1 (zh) | 一种低分子量硫酸软骨素及其制备方法 | |
CN103755838B (zh) | 一种肝素钠的制备方法 | |
CN101168570B (zh) | 海带硫酸多糖的降解方法 | |
CN107011454B (zh) | 一种低分子量高硫酸化的海参岩藻聚糖硫酸酯制备方法 | |
Tan et al. | In vitro simulated digestion of and microbial characteristics in colonic fermentation of polysaccharides from four varieties of Tibetan tea | |
KR20110029492A (ko) | 히알루론산의 분자량을 조절하는 방법 | |
CN110541016A (zh) | 一种香菇多糖的提取纯化方法 | |
CN106188327B (zh) | 一种降解含β-1,4-糖苷键的大分子量多糖的方法 | |
CN109053919A (zh) | 一种降解银耳多糖的方法 | |
CN1233664C (zh) | 一种制备水溶性壳聚糖的方法 | |
RU2422044C1 (ru) | Способ получения пектина и пищевых волокон из тыквенного жома | |
CN111978434A (zh) | 精品肝素钠的分离提纯方法 | |
CN101851259A (zh) | 硒壳寡糖及其制备方法 | |
CN113248633A (zh) | 一种低分子壳聚糖的制备方法 | |
KR20040105523A (ko) | 갈조류로 부터 생리활성물질 연속추출 및 기능성 식품제조 | |
CN105884936A (zh) | 一种肝素钠的制备方法 | |
WO2024058256A1 (ja) | 多糖から単糖又はオリゴ糖を製造する方法、該製造方法に用いられる溶解液、並びに単糖若しくはオリゴ糖を含む組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB02 | Change of applicant information |
Address after: 264006 No. 7, Changbai Mountain Road, Yantai economic and Technological Development Zone, Shandong, China Applicant after: YANTAI DONGCHENG PHARMACEUTICAL GROUP Co.,Ltd. Address before: 264006 No. 7, Changbai Mountain Road, Yantai economic and Technological Development Zone, Shandong, China Applicant before: YANTAI DONGCHENG BIOCHEMICALS CO.,LTD. |
|
COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: YINAN DONGYUAN BIOENGINEERING CO., LTD. TO: YANTAI DONGCHENG PHARMACEUTICAL GROUP CO., LTD. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Preparation method of heparin sodium Effective date of registration: 20171219 Granted publication date: 20160120 Pledgee: Bank of Qingdao Co. Yantai branch Pledgor: YANTAI DONGCHENG PHARMACEUTICAL GROUP Co.,Ltd. Registration number: 2017370010094 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20190301 Granted publication date: 20160120 Pledgee: Bank of Qingdao Co. Yantai branch Pledgor: YANTAI DONGCHENG PHARMACEUTICAL GROUP Co.,Ltd. Registration number: 2017370010094 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A preparation method of heparin sodium Effective date of registration: 20220613 Granted publication date: 20160120 Pledgee: Yantai Branch of Guangfa Bank Co.,Ltd. Pledgor: YANTAI DONGCHENG PHARMACEUTICAL GROUP Co.,Ltd. Registration number: Y2022980007629 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230721 Granted publication date: 20160120 Pledgee: Yantai Branch of Guangfa Bank Co.,Ltd. Pledgor: YANTAI DONGCHENG PHARMACEUTICAL GROUP Co.,Ltd. Registration number: Y2022980007629 |